Andy Mattes, CEO of Coherent and former leader at notable firms like Siemens and Diebold, shares his extensive insights on the intricacies of mergers and acquisitions. He discusses the essential skills CEOs must acquire, such as navigating competitive bidding and ensuring clear communication with stakeholders. Andy highlights the role of mid-cap companies in sustaining customer loyalty and delves into the emotional intelligence required for successful negotiations. His experience illustrates the challenges and learning curves CEOs face in the M&A landscape.
33:48
forum Ask episode
web_stories AI Snips
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
volunteer_activism ADVICE
Maintain Transparency with Board
Never surprise your board with M&A activities to maintain trust and alignment.
Regularly update your board with strategy and target reviews to prepare for opportunities.
question_answer ANECDOTE
Navigating Intense Bidding War
Announced a deal and then faced 11 unsolicited topping bids in a heated bidding war.
Managed multiple negotiations simultaneously with rigorous diligence and legal oversight.
volunteer_activism ADVICE
Five Deal Failure Pitfalls
Avoid excessive deal complexity and mixed archetypes to prevent failure.
Address culture head-on post-merger to secure integration and value creation.
Get the Snipd Podcast app to discover more snips from this episode
Mergers and acquisitions are among the more complex processes new CEOs have to learn, whether they’re in the role for the first time or taking over at a new company. Andreas “Andy” W. Mattes has navigated this multiple times in his roles as CEO of Siemens Communications, Diebold, and later of Diebold Nixdorf, and now of the laser technology company Coherent. In this discussion with M&A practice leader Jake Henry, Andy talks about the roller-coaster ride that M&A can be, and the critical M&A skills he had to learn as a CEO, including how to best deal with competing bids and making time to commune with other CEOs.
Jake is the global co-leader of McKinsey’s M&A Practice, which includes mergers, acquisitions, integrations, joint ventures, and divestitures. He previously led our Life Sciences Practice globally, where he guided pharmaceutical and medical-technology company executives on matters of corporate strategy, growth strategy, and operational excellence for more than twenty years.